Key result
ESR ≥50 mm/h is linked to ~186-fold higher odds of pediatric pericarditis recurrence.
Why the study?
The predisposing factors for pericarditis recurrence in the pediatric population have not yet been established.
What are the predictive factors for recurrence of pediatric acute pericarditis, and how do treatment choices affect recurrence rates?
Cohort (n=72)
No
What are the predictive factors for recurrence of pediatric acute pericarditis, and how do treatment choices affect recurrence rates?
Odds Ratio: 186.3
p-value: p=0.003
High inflammatory markers, non-idiopathic etiology, and absence of myocarditis are independent predictors of recurrence in pediatric acute pericarditis, with NSAIDs and colchicine being the preferred treatments to minimize recurrence.
No takes yet. Share an insight, caveat, or question.
May inform risk stratification in pediatric pericarditis; hypothesis-generating for prevention, needs prospective validation.
Krasić et al. (2020) conducted a cohort in pediatric acute pericarditis (n=72). Clinical and laboratory risk factors (e.g., ESR≥50mm/h, absence of myocarditis) vs. Patients without these risk factors was evaluated on Pericarditis recurrence (OR 186.3, p=0.003). Independent risk factors for pediatric pericarditis recurrence included ESR≥50mm/h (OR 186.3, p=0.003), absence of myocarditis (OR 15.2, p=0.05), CRP≥125mg/L, and non-idiopathic etiology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: